Get started

BMY

TRADE IDEA: BMY MARCH/APRIL 45/52.5 UPWARD CALL DIAGONALMetrics: Max Loss On Setup: $443/contract Max Profit On Setup: $307/contract; $153/contract at 50% max for 34.5% ROC Break Even on Setup: 49.43 versus 50.18 spot Debit Paid to Spread Width Ratio: 59.1% Theta: 1.22 Delta: 31.54 Notes: With earnings on Thursday before market open and the underlying at the low end of its 52-week range, I'm looking at taking a bullish assumption directional shot without putting a ton of risk on the line to do it (which is why, in part, I'm going March/April instead of my standard split month; longer dated back months cost more, since you'll need to widen out to get a favorable break even and/or a decent debit paid to spread width ratio). That being said, a lot of these look sexier during off hours than when New York opens, so keep that in mind. The setup, after all, is currently bid 4.12/mid 4.43/ask 4.74 (off hours), which is awfully wide ... . The natural alternative is to just short put at the March 45 (paying 1.10 at the mid), but that'll tie up around 8.75 in buying power on margin, with a return on capital of 6.3% at 50% max and invoke a full notional in cash secured of 43.89. This is basically why I like to go defined with a lot of stuff that I'm not interested in buying and holding -- better return on cap, less buying power deployed, similar or better gross profit metrics, particularly in small cash secured accounts where you haven't got a ton of cash sloshing around to do a short put/acquire/cover cycle.
NYSE:BMYLong
by NaughtyPines
Timing the Next Market Top; Don't Wait Too LongI keep narrowing my projection for the top of the market as more days elapse and more data comes in. I have been contrarian to the 'pundits' and still strongly believe the market will top before the end of 2018. I am right now projecting a near-term top to occur by the end of this week or beginning of next week around 2930. This will wrap up intermediate wave 3 which is presently in minor wave 5, minute wave 5. I have intermediate wave 4 ending down around 2841 around October 5, 2018. After that, the final market top should occur between November 1 and November 16, 2018. The final top should occur slightly above 3000. I initially forecasted the top above 3100, but do not see the top occurring higher than 3070. All of these moves can be monitored in the interactive chart below. The white box was one of my more recent projections, but the green box is my current forecasted zone for the top. I recently published my article detailing 8 stocks that have been great forecasters of market tops. These symbols indicated the tops in 1987, 2000, and 2008. The full article is free as always at ElliottWaveIdeas.
SP:SPXLong
by StockSignaler
1
[BMY] SELL SETUPSimple Sell Setup with a interesting Risk Ratio ( > 1:3 ). Details below or on chart: FUNDAMENTAL NOTE: Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. SETUP MODE --------------------------------------- # ACCOUNT BALANCE: 10K # --------------------------------------- - SELL AREA: 55.60/55.95 - STOP LOSS: 56.85 - TARGET: 52.00/51.50 ===================== MONEY MANAGEMENT --------------------------------------- # SELL: 10.000$ (Risk: 3%) # --------------------------------------- - SIZE: 200 lots/shares - POTENTIAL LOSS: 300$ - POTENTIAL GAIN: 1.100$ TRADER NOTE: Minimun Account: 1.000$ (20 lots/shares) ...Thank you for your support and trade with care!
NYSE:BMYShort
by TheAnonymousBanker
1
I am buying $BMY right here...I am buying 5,000 shares of Bristol-Myers Squibb Co (NYSE:BMY). Just last week the stock reported stellar earnings and jumped sharply higher. Since then, in a week biotech/pharma market, $BMY has slowly pulled back. This slow pullback is called bullish consolidation and is actually setting up to rocket higher. With the stock trading off 52 week lows, it is a low risk/higher reward trade. Add the bullish consolidation in and it is a no brainer as a buy. Want to get alerted when I buy stocks in real-time? Sign up to Verified Investing and follow me. Anytime I buy a stock/ETF, you will get an email. You can then opt-into the trade getting my exact entry price, target and stop. Joining Verified Investing is free, members only reward me (a Verified Trader) with a few Dollars IF they get big winning trade information.
NYSE:BMYLong
by jenny_rebekka
4
Bristol-Myers offering an easy 6% $BMY has been struggling the first half of this year, but things are about to get worse. So far this year, each downward slide has been able to hold Sep/Oct13 resistance line converging with the 61.8% fib from the late Aug13 breakout level. Last week that crucial line was severed aided by the downward pressure of a death cross. This lower low break on high selling pressure demonstrates the bears are in control. With all momentum indicators on the weekly in firm landslide mode, I think this daily dead cat bounce into prior support/61.8% fib this week on fading volume is a nice opportunity to pick up some July puts for a profit target of around 44.30, where prior resistance and a breakaway gap last year converge.
NYSE:BMYShort
by Nick_C_